All Infection Prevention & Control articles – Page 22
-
NewsOne strategy to block both drug-resistant bacteria and influenza: new broad-spectrum infection prevention approach validated
A new paper moves beyond traditional infection control strategies reliant on antibiotics and vaccines by introducing a new approach that primes the immune system before infection occurs.
-
NewsHPV cancer vaccine slows tumor growth, extends survival in preclinical model
Scientists discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to formulations that supercharge the immune system’s ability to attack HPV-driven tumors.
-
NewsStiff gels slow germs: New study maps hydrogel properties that control bacterial growth
Scientists has found that firmer, lower water content hydrogels limit bacterial growth, with implications for designing antibacterial coatings, infection models, and advanced medical materials.
-
NewsResearchers develop new inhalable treatment for TB
Researchers have developed an inhalable, immunomodulating, biocompatible nanoparticle system encapsulating rifampin, one of the most important TB drugs.
-
NewsHow food shortages reprogram the immune system’s response to infection
When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy. This reconfiguration is crucial to combating infections amid food insecurity.
-
NewsAvian malaria widespread across Hawaiʻi bird communities, new study finds
A new study shows that avian malaria can be transmitted by nearly all forest bird species in Hawaiʻi, helping explain why the disease is present almost everywhere mosquitoes are found across the islands.
-
NewsBacterial hitchhikers can give their hosts super strength
Molecular hitchhikers living within bacteria can make their hosts extra resistant to medical treatment by corralling them into tightly packed groups. The study introduces a previously unknown avenue through which bacterial infections can become more difficult to treat.
-
NewsShorter treatment regimens are safe options for preventing active tuberculosis
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects.
-
NewsGenotype-specific response to 144-week entecavir therapy for HBeAg-positive chronic hepatitis B
HBV genotype B demonstrates superior histological responses to ETV therapy compared with genotype C, supporting the clinical value of HBV genotyping for personalized CHB management. These findings highlight the importance of considering viral genotype when evaluating treatment outcomes.
-
NewsResearchers identify strategies for preventing the most infectious strains of S. aureus in the NICU
A new study has identified which strains of Staphylococcus aureus – commonly known as staph – are commonly transmitted in neonatal intensive care units and which specific strains are most likely to cause invasive and serious infections.
-
NewsStudy reveals how chills develop and support the body’s defense against infection
Researchers in Japan have identified the neural mechanism behind chills and the instinct to increase body temperature during infection.
-
NewsAccomplices in the spotlight: When the interaction between fungi and bacteria becomes a dangerous alliance
Researchers discover new co-infection strategies of Candida albicans and Enterococcus faecalis. Only some E. faecalis strains significantly increased cell damage when infected simultaneously with Candida albicans. These strains produced cytolysin, a toxin that perforates cell membranes and kills the cells.
-
NewsTechnology transfer for Corallopyronin A successfully completed with Phyton Biotech
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address neglected tropical diseases.
-
NewsObesity linked to one in 10 infection deaths globally
Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new study. People with obesity face a 70% higher risk of hospitalisation or death from an infection than those of a healthy weight.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsEthris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), have announced a strategic research collaboration to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
-
NewsScientists uncover link between influenza and heart disease
Researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.
-
NewsPathogen risk: Removing southern African fences may help wildlife, boost economy
Fences intended to protect cattle from catching diseases from wildlife and other livestock in southern Africa are in disrepair, restrict wild animal migrations and likely intensify human-elephant conflict – but a plan to remove key sections could make both livestock and wildlife safer.
-
NewsConstruction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
A new article discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
-
NewsDiscovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
A new article publication discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.